Evaluating a Strategy for Killing HIV-Infected Cells
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV.
-Einstein News Release, May 3, 2022
Einstein-Developed Treatment Strategy May Lead to HIV Cure
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published in the Journal of Clinical Investigation.
-Einstein News Release, October 21, 2021
Can an Immune Strategy Used to Treat Cancer also Wipe Out HIV Infections?
Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.
-Science, August 08, 2019
A research team at Albert Einstein College of Medicine led by Harris Goldstein, M.D., has demonstrated that genetically engineered T cells, dubbed duoCAR-T cells, can effectively target and kill HIV-infected T cells in mice, acting as a functional cure for HIV infection by eliminating these latently infected cells.
-Einstein News Release, November 15, 2022
Borrowing from breakthroughs in cancer immunotherapy, infectious disease specialists at Einstein and other institutions have devised an experimental treatment that could lead to a “functional cure” for HIV infection.
-Einstein News Release, August 07, 2019
Albert Einstein College of Medicine Receives $11.3M NIH Grant to Expand the Einstein-Rockefeller-CUNY Center for AIDS Research
Getting Closer to an HIV Cure
Why Is the HIV Vaccine Taking So Long?
Harris Goldstein, M.D., discusses the difficulty of developing a vaccine for HIV. In perhaps one of the greatest analogies in science journalism, one researcher compared the virus's MO to the stealthy Jason Bourne. "As soon as you think you have Bourne, he changes his appearance. HIV does the same thing."
-Vice, August 25, 2017